Giant cell tumor of the tendon sheath: A retrospective study of 28 cases

Rodrigues, Callista; Desai, Sangeeta; Chinoy, Roshni

doi:10.1002/(sici)1096-9098(199806)68:2<100::aid-jso5>3.0.co;2-a

Cited by 60 publications

(38 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1][2][3][4] Postoperative radiotherapy may reduce the recurrence rate to 4%. 4,5 We reviewed outcomes of 106 patients after complete excision of the giant cell tumour of the tendon sheath of the hand, with or without postoperative radiotherapy.…”

mentioning

confidence: 99%

Giant Cell Tumour of the Tendon Sheath of the Hand

Garg

Kotwal

2011

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

purpose. To review outcomes of 106 patients after complete excision of the giant cell tumour of the tendon sheath of the hand, with or without postoperative radiotherapy. Methods. Records of 77 women and 29 men aged 11 to 61 (mean, 31) years who underwent excision of giant cell tumours of the tendon sheath of the hand were reviewed. All patients presented with gradually progressive swelling; only 3 of them also presented with pain. The lesions were located on the dorsal aspect (n=11), the palmar aspect (n=66), both aspects (n=10), or circumferentially (n=14). No patient had multiple lesions. Five patients had bony erosion and 3 had neurovascular bundle involvement. results. The mean follow-up period was 12 (range, 4-22) years. 56 patients with well-encapsulated giant cell tumour in the palmer and/or dorsal aspects were classified as at low risk of recurrence. The remaining 50 patients were classified as at high risk of recurrence and underwent postoperative radiotherapy. None of Giant cell tumour of the tendon sheath of the hand

show abstract

mentioning

confidence: 99%

Giant Cell Tumour of the Tendon Sheath of the Hand

Garg

Kotwal

2011

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

show abstract

“…Most authors agree that the best way to avoid recurrence is to perform complete surgical excision. 10 GCTTS, on exploration may reveal extensions that go around and under several structures including the neurovascular bundle and it may be the reason for the high recurrence rate. Surgical incisions should be planned in such a way that allows the surgeon to reach the tumour extensions both dorsally and ventrally.…”

Section: Discussionmentioning

confidence: 99%

Giant cell tumor of tendon sheath

et al. 2017

View full text Add to dashboard Cite

Giant Cell Tumor of Tendon Sheath (GCTTS) is the second most common benign tumour affecting hand after ganglion. The tumor generally affects individuals between the age of 30 and 50 years, and is found more often in women than men. The etiological factors responsible for GCTTS are unclear. Some authors consider it as an inflammatory process arising as a consequence of chronic antigenic stimulation. Local excision with or without radiotherapy is the treatment of choice. We recently encountered two cases of Giant cell tumor involving tendon sheath of ring finger in one case and thumb in another case. Both were managed surgically with good results. There has been no evidence of recurrence till date in the follow up varying from 3-6 months.

show abstract

“…GCT-TS in large joints may be more difficult to diagnose, as there are few symptoms which are nonspecific [6,7,8]. The differential diagnosis includes malignant fibrous histiocytoma, ganglion, synovial sarcoma, liposarcoma, and lipoma.…”

Section: Discussionmentioning

confidence: 99%

Painful Giant Cell Tumor of the Suprapatellar Pouch of the Knee Joint: A Case Report

Fatah¹

2017

jot

View full text Add to dashboard Cite

Introduction. Giant cell tumor of the tendon sheath (GCT-TS) is a benign tumor which most commonly affects hand tendons but rarely affects the large joints. GCT-TS usually occurs in individuals between the ages of 30 and 50 years, with a predominance for females, and exhibits the tendency for local recurrence following surgical resection. Marginal excision is the standard treatment of GCT-TS. Case presentation. The case studied is a 51-year-old female with a one-year history of gradual onset of pain in the left knee. She denied any history of trauma. The pain was worse at night and during walking and she was on regular pain medication. She was referred as a case of osteoarthritis not responding to conservative treatment. The purpose of this report is to emphasize the possibility of other pathologies whenever the pain is not responding to usual conservative treatment even in the presence of radiological features. Discussion. GCT-TS in large joints may be more difficult to diagnose, as there are few and nonspecific symptoms. GCT-TS most frequently occurs in the digits of the hands and feet and is rarely seen in the larger joints. Although GCT-TS is a benign tumor, it has a high incidence of recurrence following resection (10-40%), Conclusion. Giant cell tumor of the suprapatellar region is unusual especially when accompanied by pain presentation in a patient who is diagnosed as another case of osteoarthritis. Careful surgical excision is effective in preventing recurrence despite relatively high recurrence rates.

show abstract

Giant cell tumor of the tendon sheath: A retrospective study of 28 cases

Cited by 60 publications

References 12 publications

Giant Cell Tumour of the Tendon Sheath of the Hand

Giant Cell Tumour of the Tendon Sheath of the Hand

Giant cell tumor of tendon sheath

Painful Giant Cell Tumor of the Suprapatellar Pouch of the Knee Joint: A Case Report

Contact Info

Product

Resources

About